TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2005

Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.

Susan M O'Brien et al.PubMed ↗Publisher ↗

No numbers read from the abstract.